Adial Pharmaceuticals
ADIL
#10837
Rank
NZ$24.24 M
Marketcap
NZ$9.23
Share price
36.12%
Change (1 day)
1,627.85%
Change (1 year)

EPS for Adial Pharmaceuticals (ADIL)

EPS in 2026 (TTM): NZ-$33.41

According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$35.35. In 2025 the company made an earnings per share (EPS) of NZ-$21.81 an increase over its 2024 EPS that were of NZ-$124.32.

EPS history for Adial Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$33.4153.21%
2025NZ-$21.81-82.46%
2024NZ-$124.32-24.43%
2023NZ-$164.52-71.68%
2022NZ-$580.85-51.12%
2021NZ-$1,18819.54%
2020NZ-$993.97-0%
2019NZ-$993.97-64.34%
2018NZ-$2,7881072.27%
2017NZ-$237.80136.68%
2016NZ-$100.47-56.33%
2015NZ-$230.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.11-99.69% Bahamas
NRC Health
NRC
NZ$0.53-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA